Wilk Auslander LLP

New York

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases23

Challenger50%

Patent Owner50%

NPE50%

wilk-auslander

wilkauslander.com

Practice Areas

BiotechDesignSemicond., Optic

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
12/26/23	Endo Pharma Inc v. Impax Laboratories Inc 1:12-CV-08317 ( S.D. NY )	SEALED MATERIALS DISPOSED: Document(s) 128 and 168 were destroyed since the filing party did not retrieve the material(s) within 30 days of the date indicated. The sealed record(s) were destroyed on 12/26/2023.(nmo) (Entered: 12/26/2023)
12/26/23	Endo Pharma Inc v. Impax Laboratories Inc 1:12-CV-08317 ( S.D. NY )	SEALED MATERIALS DISPOSED: Document(s) 65, 127 and 135 were destroyed since the filing party did not retrieve the material(s) within 30 days of the date indicated. The sealed record(s) were destroyed on 12/26/2023.(nmo) (Entered: 12/26/2023)
12/26/23	Endo Pharma Inc v. Amneal Pharma LLC 1:12-CV-08115 ( S.D. NY )	SEALED MATERIALS DISPOSED: Document(s) 120 and 161 were destroyed since the filing party did not retrieve the material(s) within 30 days of the date indicated. The sealed record(s) were destroyed on 12/26/2023.(nmo) (Entered: 12/26/2023)
12/26/23	Endo Pharma Inc v. Amneal Pharma LLC 1:12-CV-08115 ( S.D. NY )	SEALED MATERIALS DISPOSED: Document(s) 119 were destroyed since the filing party did not retrieve the material(s) within 30 days of the date indicated. The sealed record(s) were destroyed on 12/26/2023.(nmo) (Entered: 12/26/2023)
04/17/19	Endo Pharma Inc v. Impax Laboratories Inc 1:13-CV-00435 ( S.D. NY )	Costs
04/15/19	Endo Pharma v. Teva Pharma USA 1:12-CV-08060 ( S.D. NY )	BILL OF COSTS NOTICE OF TAXATION WITHDRAWN re: [296] Amended Bill of Costs Notice of Taxation,. Document filed by Endo Pharmaceuticals Inc. .(Gagliardi, Sharon)
03/07/19	Endo Pharma Inc v. Actavis Inc 1:13-CV-00436 ( S.D. NY )	MANDATE of USCA (Certified Copy) as to 149 Notice of Appeal to the Federal Circuit, filed by Grunenthal GMBH, 184 Amended Notice of Appeal, filed by Grunenthal GMBH. USCA Case Number 2015-2031. Upon consideration of the parties joint response to the courts February 21, 2019, order to show cause, IT IS ORDERED THAT: The above-captioned appeals are dismissed.. Peter R. Marksteiner, Clerk USCA for the Federal Circuit. Issued As Mandate: 3/7/2019. (nd) (Entered: 03/07/2019) MANDATE of USCA (Certified Copy) as to 149 Notice of Appeal to the Federal Circuit, filed by Grunenthal GMBH, 184 Amended Notice of Appeal, filed by Grunenthal GMBH. USCA Case Number 2015-2031. Upon consideration of the parties joint response to the courts February 21, 2019, order to show cause, IT IS ORDERED THAT: The above-captioned appeals are dismissed.. Peter R. Marksteiner, Clerk USCA for the Federal Circuit. Issued As Mandate: 3/7/2019. (nd) (Entered: 03/07/2019)
11/01/18	Endo Pharma Inc v. Actavis Inc 1:13-CV-00436 ( S.D. NY )	NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a DECISON proceeding held on 10/4/18 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...(McGuirk, Kelly) (Entered: 11/01/2018) NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a DECISON proceeding held on 10/4/18 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...(McGuirk, Kelly) (Entered: 11/01/2018)
11/01/18	Endo Pharma Inc v. Actavis Inc 1:13-CV-00436 ( S.D. NY )	TRANSCRIPT of Proceedings re: DECISON held on 10/4/2018 before Judge J. Paul Oetken. Court Reporter/Transcriber: Carol Ganley, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/23/2018. Redacted Transcript Deadline set for 12/3/2018. Release of Transcript Restriction set for 1/30/2019.(McGuirk, Kelly) (Entered: 11/01/2018) TRANSCRIPT of Proceedings re: DECISON held on 10/4/2018 before Judge J. Paul Oetken. Court Reporter/Transcriber: Carol Ganley, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/23/2018. Redacted Transcript Deadline set for 12/3/2018. Release of Transcript Restriction set for 1/30/2019.(McGuirk, Kelly) (Entered: 11/01/2018)
10/05/18	Endo Pharma Inc v. Actavis Inc 1:13-CV-00436 ( S.D. NY )	ORDER granting 207 Motion to Vacate. For the reasons given at the October 4, 2018, status conference, Grunenthal GmbHs motion to vacate is GRANTED. Accordingly, the portions of this Courts March 17, 2015, summary judgment order (Case No. 12cv8060, Dkt. No. 148; Case No. 12cv8317, Dkt. No. 137; Case No. 13cv435, Dkt. No. 118; Case No. 13cv436, Dkt. No. 117) pertaining to United States Patent Number 8,114,383 and the portions of this Courts August 14, 2015, findings of fact and conclusions of law (Case No. 12cv8060, Dkt. No. 220; Case No. 12cv8317, Dkt. No. 154; Case No. 13cv435, Dkt. No. 135; Case No. 13cv436, Dkt. No. 141) pertaining to United States Patent Number 8,309,060 are hereby vacated. The Clerk of Court is directed to close the motions at Case Number 12cv8060, Docket Number 290; Case Number 12cv8317, Docket Number 218; Case Number 13cv435, Docket Number 199; and Case Number 13cv436, Docket Number 207. (Signed by Judge J. Paul Oetken on 10/5/2018) (mro) (Entered: 10/05/2018) ORDER granting 207 Motion to Vacate. For the reasons given at the October 4, 2018, status conference, Grunenthal GmbHs motion to vacate is GRANTED. Accordingly, the portions of this Courts March 17, 2015, summary judgment order (Case No. 12cv8060, Dkt. No. 148; Case No. 12cv8317, Dkt. No. 137; Case No. 13cv435, Dkt. No. 118; Case No. 13cv436, Dkt. No. 117) pertaining to United States Patent Number 8,114,383 and the portions of this Courts August 14, 2015, findings of fact and conclusions of law (Case No. 12cv8060, Dkt. No. 220; Case No. 12cv8317, Dkt. No. 154; Case No. 13cv435, Dkt. No. 135; Case No. 13cv436, Dkt. No. 141) pertaining to United States Patent Number 8,309,060 are hereby vacated. The Clerk of Court is directed to close the motions at Case Number 12cv8060, Docket Number 290; Case Number 12cv8317, Docket Number 218; Case Number 13cv435, Docket Number 199; and Case Number 13cv436, Docket Number 207. (Signed by Judge J. Paul Oetken on 10/5/2018) (mro) (Entered: 10/05/2018)